TLR2 and Parkinson disease: We have previously shown that PD patients with a higher risk of progressing to dementia have increased activation of the innate immune system, including an increase in classical (inflammatory) monocytes, and increased monocyte expression of both TLR2 and TLR4 compared to patients at low risk of dementia [74].